30 related articles for article (PubMed ID: 2140663)
21. Ovulation inhibitors containing cyproterone acetate or desogestrel in the treatment of hyperandrogenic symptoms.
Erkkola R; Hirvonen E; Luikku J; Lumme R; Männikkö H; Aydinlik S
Acta Obstet Gynecol Scand; 1990; 69(1):61-5. PubMed ID: 2140663
[TBL] [Abstract][Full Text] [Related]
22. The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms - a review.
Bitzer J; Römer T; Lopes da Silva Filho A
Eur J Contracept Reprod Health Care; 2017 Jun; 22(3):172-182. PubMed ID: 28447864
[TBL] [Abstract][Full Text] [Related]
23. Use of cyproterone acetate/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects.
Ruan X; Kubba A; Aguilar A; Mueck AO
Eur J Contracept Reprod Health Care; 2017 Jun; 22(3):183-190. PubMed ID: 28463030
[TBL] [Abstract][Full Text] [Related]
24. The role of combined oral contraceptives in the management of acne and seborrhea.
del Marmol V; Teichmann A; Gertsen K
Eur J Contracept Reprod Health Care; 2004 Jun; 9(2):107-24. PubMed ID: 15449823
[TBL] [Abstract][Full Text] [Related]
25. Treatment of hirsutism and acne with cyproterone acetate.
Miller JA; Jacobs HS
Clin Endocrinol Metab; 1986 May; 15(2):373-89. PubMed ID: 2941191
[No Abstract] [Full Text] [Related]
26. Progestogens with antiandrogenic properties.
Raudrant D; Rabe T
Drugs; 2003; 63(5):463-92. PubMed ID: 12600226
[TBL] [Abstract][Full Text] [Related]
27.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
29.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
